Feb. 13, 2024—Bio-Rad Laboratories has published its third workbook in a series that offers Professional Acknowledgement for Continuing Education credits.
Read More »Bio-Rad cardiac control compatible with Beckman analyzers
Nov. 2, 2023—Bio-Rad Laboratories has announced the expanded compatibility of its cardiac control, Cardiac Advance, to include Beckman Coulter instruments.
Read More »Bio-Rad launches bulk urine, CSF negative controls
July 2023—Bio-Rad Laboratories launched two Exact Diagnostics products, Bulk Urine Negative and Bulk CSF Negative controls. The bulk urine negative control is intended to be validated as an independent external quality run control to monitor the absence of adenovirus, BK virus, Candida auris, Chlamydia trachomatis, cytomegalovirus, John Cunningham virus, Mycoplasma genitalium, Neisseria gonorrhoeae, Trichomonas vaginalis, and Zika virus in various molecular assays. The bulk CSF negative control is an independent external quality run control intended to monitor the absence of Anaplasma phagocytophilum, Babesia microti, Bartonella quintana, Borrelia burgdorferi, Ehrlichia chaffeensis, enterovirus, herpes simplex virus 1 and 2, and varicella-zoster virus in various molecular assays.
Read More »Bio-Rad launches Cardiac Advance quality controls
April 18, 2023–Bio-Rad Laboratories has launched Cardiac Advance, a four-level multianalyte cardiac quality control for high-sensitivity troponin testing.
Read More »Bio-Rad launches Exact Diagnostics CT/NG, STI run controls
Oct. 28, 2022—Bio-Rad Laboratories has launched two Exact Diagnostics products, CT/NG Positive Run Control, intended to be used with Chlamydia trachomatis and Neisseria gonorrhoeae molecular assays, and STI Negative Run Control, which monitors the absence of Chlamydia trachomatis and Neisseria gonorrhoeae in various molecular assays, the company says, and can be used to detect errors in laboratory testing procedures, including potential contamination events, while controlling for sample adequacy assessment.
Read More »Bio-Rad introduces Unity Next Peer QC
Oct. 14, 2022—Bio-Rad Laboratories has launched Unity Next Peer QC, a quality control peer comparison software that provides instant access to peer reporting and comprehensive quality control data.
Read More »Bio-Rad releases three StarBright ultraviolet dyes
July 2022—Bio-Rad Laboratories introduced three StarBright dyes designed for use with a 355 nanometer UV laser in flow cytometry applications. StarBright UltraViolet 510, 665, and 795 dyes offer exceptional brightness, the company says, with narrow excitation and emission profiles for precise resolution.
Read More »Bio-Rad launches two negative run controls
July 14, 2022—Bio-Rad Laboratories launched two new Exact Diagnostics negative run controls.
Read More »Bio-Rad launches CFX Duet Real-Time PCR system
May 26, 2022—Bio-Rad Laboratories has launched the CFX Duet Real-Time PCR system to support researchers in developing singleplex and duplex quantitative PCR assays.
Read More »Bio-Rad adds SARS-CoV-2 S gene delta-kappa variants control
January 2022—Bio-Rad Laboratories launched its Exact Diagnostics SARS-CoV-2 S Gene Delta-Kappa Variants Control for research testing. The control includes lineages B.1.617.1, B.1.617.2 (AY sublineages), and B.1.617.3. The product is an addition to the company’s SARS-CoV-2 S gene variants controls alpha, beta, epsilon, and gamma, which were released in August.
Read More »Bio-Rad SARS-CoV-2 variant neutralization antibody assays
Dec. 20, 2021—Bio-Rad Laboratories launched the Bio-Plex Pro Human SARS-CoV-2 Variant Neutralization Antibody Assays, for research use only.
Read More »Bio-Rad launches enhanced Liquichek diabetes control
December 2021—Bio-Rad Laboratories launched an enhanced version of its Liquichek Diabetes Control. The liquid, human whole-blood–based control comes in three levels to address the HbA1c precision monitoring needs of a wide range of test methods.
Read More »Bio-Rad RP positive run control for SARS-CoV-2
December 2021—Bio-Rad announced its Exact Diagnostics RP Positive Run Control for syndromic respiratory panels is now available with inactivated whole virus for SARS-CoV-2. The unassayed external quality control contains 23 respiratory analytes in one vial and is intended to monitor the performance of clinical respiratory assays. The control is a combination of whole, intact virus and bacteria that have been heated or chemically inactivated and synthetic RNA transcripts.
Read More »Bio-Rad launches CFX Opus Dx RT-PCR detection systems
November 2021—Bio-Rad launched its CFX Opus 96 Dx and CFX Opus 384 Dx systems, real-time PCR detection systems that have been listed with the FDA for IVD testing and that meet the CE-IVD requirement for IVD use in Europe. Both instruments are also registered with regulatory bodies for IVD use in Singapore and Canada.
Read More »Bio-Rad launches enhanced Liquichek diabetes control
Nov. 1, 2021—Bio-Rad Laboratories launched an enhanced version of its Liquichek Diabetes Control.
Read More »Bio-Rad launches IgA, IgM SARS-CoV-2 Bio-Plex Pro panels
Sept. 30, 2021—Bio-Rad Laboratories launched its Bio-Plex Pro Human IgA and IgM SARS-CoV-2 panels to detect IgA and IgM antibodies against four SARS-CoV-2 antigens.
Read More »Bio-Rad launches SARS-CoV-2 S gene variant controls
Aug. 13, 2021—Bio-Rad Laboratories has launched SARS-CoV-2 S gene alpha, beta, gamma, and epsilon variant controls.
Read More »Bio-Rad launches InteliQ Diabetes Control
July 2021—Bio-Rad Laboratories launched its InteliQ Diabetes Control, the 10th product offered in the InteliQ format. The InteliQ Diabetes Control includes three distinct levels that aim to address HbA1c precision monitoring needs of a wide range of test methods. InteliQ quality controls are designed to empower labs to automate their QC workflow with load-and-go efficiency, and users have access to the Unity data management program.
Read More »Bio-Rad launches SARS-CoV-2/FluA/FluB RT-PCR Kit in Europe
July 14, 2021—Bio-Rad launched its Reliance SARS-CoV-2/FluA/FluB RT-PCR Kit (IVD) for European markets after having met the CE-IVD mark requirements.
Read More »Bio-Rad launches SARS-CoV-2 variant RT-PCR assays
April 21, 2021—Bio-Rad Laboratories launched SARS-CoV-2 Variant RT-PCR Assays for research use only.
Read More »Bio-Rad introduces Bio-Plex IgG SARS-CoV-2 serology assays
March 5, 2021—Bio-Rad Laboratories launched the Bio-Plex Pro Human IgG SARS-CoV-2 N/RBD/S1/S2 4-Plex Panel, a qualitative multiplex immunoassay kit that detects IgG antibodies against four SARS-CoV-2 antigens in less than three hours.
Read More »Bio-Rad Reliance RT-PCR COVID assays granted EUA
Feb. 23, 2021–Bio-Rad Laboratories announced that its Reliance SARS-CoV-2/FluA/FluB RT-PCR and Reliance SARS-CoV-2 RT-PCR assay kits were granted emergency use authorization by the FDA.
Read More »Bio-Rad launches SARS-CoV-2, flu, RSV run controls
Dec. 1, 2020—Bio-Rad Laboratories launched its SARS-CoV-2, Flu, RSV positive and negative run controls.
Read More »Bio-Rad RT-PCR system available for COVID-19 testing
May 26, 2020—Bio-Rad Laboratories announced that its CFX96 Dx Real-Time PCR System has been listed with the FDA for IVD testing and may be used to help in the diagnosis of COVID-19.
Read More »Bio-Rad FDA clearances
October 2019—Bio-Rad Laboratories received FDA 510(k) clearance for its IH-500, an automated random access system for blood typing and screening, designed for small to medium-size laboratories. The system can process Bio-Rad’s range of IH gel cards for ABO blood grouping, reverse testing, phenotyping, Rh subgroups, antibody screening, antibody identification, single antigen testing, direct AHG testing, and crossmatching. In a separate ...
Read More »FDA clears digital PCR test for monitoring CML therapy
Feb. 19, 2019—Bio-Rad Laboratories announced that its QXDx AutoDG ddPCR System, which uses the company’s droplet digital PCR technology, and the QXDx BCR-ABL %IS Kit received FDA clearance. The system and kit, when used together, can monitor molecular response to treatment in patients with chronic myeloid leukemia. “Bio-Rad is proud to announce our first FDA-cleared liquid biopsy test in oncology,” ...
Read More »Liquichek AMH Control
July 2018—Bio-Rad Laboratories has launched its Liquichek AMH Control for reproductive health testing.
Read More »Newsbytes, 10/15
October 2015—A decade later, online laboratory handbook gets makeover: Ten years ago, when Massachusetts General Hospital created an online laboratory handbook, the event crowned many hours of programming and coding by a team of pathologists, who were convinced their labors would dramatically streamline access to information.
Read More »Quality assurance service programs
February 2013—Bio-Rad Laboratories has released three External Quality Assurance Service (EQAS) programs for clinical laboratories and near-patient/point-of-care settings worldwide. They are cardiac markers, ethanol/ammonia, and lipids.
Read More »